|
Daratumumab, bortezomib and dexamethasone (DVd) vs bortezomib and dexamethasone (Vd) in relapsed or refractory multiple myeloma (RRMM): Efficacy and safety update (CASTOR). |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Research Funding - Amgen; Celgene; Janssen; Sanofi |
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda |
|
|
Honoraria - Amgen; Celgene; Janssen-Cilag; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen-Cilag; Takeda |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Janssen; Takeda; Teva |
|
|
Consulting or Advisory Role - Novartis; Onyx |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Incyte; Novartis; Takeda |
Research Funding - Amgen; Takeda |
|
|
Employment - Chonnam National University Hwasun Hospital |
|
|
Honoraria - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda |
Research Funding - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda |
|
|
Employment - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
|
|
No Relationships to Disclose |
|
|
Employment - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Employment - Janssen Research & Development |
|
|
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Janssen-Cilag |
Speakers' Bureau - Janssen-Cilag |
Research Funding - Janssen-Cilag |